|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 2719708 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13189092.3 |
| Date of filing the European patent application | 2010-11-12 | |
| (97) | Date of publication of the European application | 2014-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-25 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (30) | Number | Date | Country code |
| 261149 P | 2009-11-13 | US |
| (72) |
Hettmann, Thore, BE
Freeman, Daniel J., US
Radinsky, Robert, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 München, DE |
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Medžiaga ir būdai, skirti su HER-3 susijusių ligų gydymui arba prevencijai |
| Material and methods for treating or preventing HER-3 associated diseases |
| Payment date | Validity (years) | Amount | |
| 2025-10-03 | 16 | 347.00 EUR |
| 2026-11-12 |